Cargando…

Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese

INTRODUCTION: China has the largest population of diabetic patients (about 116 million) in the world. As a novel model of the fat index for Chinese people, the Chinese visceral adiposity index (CVAI) was considered a reliable indicator to assess the dysfunction of visceral fat. This study aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Liang, Xu, Qianqian, Liu, Jianmin, Gao, Yang, Li, Jun, Peng, Hongye, Chen, Linli, Wang, Miyuan, Mai, Gang, Yang, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579311/
https://www.ncbi.nlm.nih.gov/pubmed/36277708
http://dx.doi.org/10.3389/fendo.2022.959860
_version_ 1784812152587026432
author Pan, Liang
Xu, Qianqian
Liu, Jianmin
Gao, Yang
Li, Jun
Peng, Hongye
Chen, Linli
Wang, Miyuan
Mai, Gang
Yang, Shuo
author_facet Pan, Liang
Xu, Qianqian
Liu, Jianmin
Gao, Yang
Li, Jun
Peng, Hongye
Chen, Linli
Wang, Miyuan
Mai, Gang
Yang, Shuo
author_sort Pan, Liang
collection PubMed
description INTRODUCTION: China has the largest population of diabetic patients (about 116 million) in the world. As a novel model of the fat index for Chinese people, the Chinese visceral adiposity index (CVAI) was considered a reliable indicator to assess the dysfunction of visceral fat. This study aimed to explore the dose–response relationship between CVAI and type 2 diabetes mellitus (T2DM) in the Chinese population, considering CVAI as a continuous/categorical variable. METHOD: Baseline and follow-up data were collected from waves 2011 and 2015, respectively, of the China Health and Retirement Longitudinal Study (CHARLS). Multivariate logistic regression models were used to explore the relationship between CVAI and T2DM. We built three models to adjust the possible effect of 10 factors (age, gender, education level, location, marital status, smoking status, drinking status, sleep time, systolic blood pressure (SBP), and diastolic blood pressure (DBP)) on the outcome. The restricted cubic splines were used to examine possible non-linear associations and visualize the dose–response relationship between CVAI and T2DM. RESULTS: A total of 5,014 participants were included, with 602 (12.00%) T2DM patients. The last CVAI quartile group (Q4) presented the highest risk of T2DM (OR, 2.17, 95% CI, 1.67–2.83), after adjusting for all covariates. There was a non-linear (U-shaped) relationship between the CVAI and the risk of T2DM (p for non-linear <0.001) in the restricted cubic spline regression model. CVAI was a risk factor of T2DM when it exceeded 92.49; every interquartile range (IQR) increment in the CVAI was associated with a 57% higher risk of developing T2DM (OR = 1.57, 95% CI = 1.36–1.83) after adjusting for potential confounders. The area under the receiver operating characteristic curve (AUC) (95% confidence interval) for CVAI was 0.623, and the optimal cutoff point was 111.2. There was a significant interaction between CVAI and gender by stratified analysis. CONCLUSION: CVAI was closely associated with the risk of T2DM and might possibly be a potential marker in predicting T2DM development. The outcome suggested that it might be better to maintain CVAI within an appropriate range.
format Online
Article
Text
id pubmed-9579311
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95793112022-10-20 Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese Pan, Liang Xu, Qianqian Liu, Jianmin Gao, Yang Li, Jun Peng, Hongye Chen, Linli Wang, Miyuan Mai, Gang Yang, Shuo Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: China has the largest population of diabetic patients (about 116 million) in the world. As a novel model of the fat index for Chinese people, the Chinese visceral adiposity index (CVAI) was considered a reliable indicator to assess the dysfunction of visceral fat. This study aimed to explore the dose–response relationship between CVAI and type 2 diabetes mellitus (T2DM) in the Chinese population, considering CVAI as a continuous/categorical variable. METHOD: Baseline and follow-up data were collected from waves 2011 and 2015, respectively, of the China Health and Retirement Longitudinal Study (CHARLS). Multivariate logistic regression models were used to explore the relationship between CVAI and T2DM. We built three models to adjust the possible effect of 10 factors (age, gender, education level, location, marital status, smoking status, drinking status, sleep time, systolic blood pressure (SBP), and diastolic blood pressure (DBP)) on the outcome. The restricted cubic splines were used to examine possible non-linear associations and visualize the dose–response relationship between CVAI and T2DM. RESULTS: A total of 5,014 participants were included, with 602 (12.00%) T2DM patients. The last CVAI quartile group (Q4) presented the highest risk of T2DM (OR, 2.17, 95% CI, 1.67–2.83), after adjusting for all covariates. There was a non-linear (U-shaped) relationship between the CVAI and the risk of T2DM (p for non-linear <0.001) in the restricted cubic spline regression model. CVAI was a risk factor of T2DM when it exceeded 92.49; every interquartile range (IQR) increment in the CVAI was associated with a 57% higher risk of developing T2DM (OR = 1.57, 95% CI = 1.36–1.83) after adjusting for potential confounders. The area under the receiver operating characteristic curve (AUC) (95% confidence interval) for CVAI was 0.623, and the optimal cutoff point was 111.2. There was a significant interaction between CVAI and gender by stratified analysis. CONCLUSION: CVAI was closely associated with the risk of T2DM and might possibly be a potential marker in predicting T2DM development. The outcome suggested that it might be better to maintain CVAI within an appropriate range. Frontiers Media S.A. 2022-10-05 /pmc/articles/PMC9579311/ /pubmed/36277708 http://dx.doi.org/10.3389/fendo.2022.959860 Text en Copyright © 2022 Pan, Xu, Liu, Gao, Li, Peng, Chen, Wang, Mai and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Pan, Liang
Xu, Qianqian
Liu, Jianmin
Gao, Yang
Li, Jun
Peng, Hongye
Chen, Linli
Wang, Miyuan
Mai, Gang
Yang, Shuo
Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese
title Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese
title_full Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese
title_fullStr Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese
title_full_unstemmed Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese
title_short Dose–response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese
title_sort dose–response relationship between chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly chinese
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579311/
https://www.ncbi.nlm.nih.gov/pubmed/36277708
http://dx.doi.org/10.3389/fendo.2022.959860
work_keys_str_mv AT panliang doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT xuqianqian doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT liujianmin doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT gaoyang doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT lijun doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT penghongye doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT chenlinli doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT wangmiyuan doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT maigang doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese
AT yangshuo doseresponserelationshipbetweenchinesevisceraladiposityindexandtype2diabetesmellitusamongmiddleagedandelderlychinese